INTRODUCTION
============

Watson and Crick proposed a structural model of DNA as a right-handed double helix ([@gkt243-B1]), called B-DNA. However, the first single-crystal X-ray structure of DNA, i.e. hexamer dCGCGCG, showed a left-handed double helix ([@gkt243-B2]). The phosphate--sugar backbone of left-handed DNA exhibits a zigzag arrangement, and is thereby called Z-DNA ([@gkt243-B2]). DNA regions containing alternating purine--pyrimidine repeat sequences typically adopt a Z-DNA structure and are called Z-DNA-forming sequences. Because Z-DNA-forming sequences are often identified in gene promoter regions ([@gkt243-B3]), it has been proposed that Z-DNA plays a role in nuclear processes, such as transcription regulation and nucleosome positioning ([@gkt243-B4],[@gkt243-B5]). Z-DNA formation has been detected under high salt conditions *in vitro* ([@gkt243-B6]), but *in vivo*, Z-DNA formation and its physiological roles in nuclear processes are largely unknown.

Heme oxygenase catalyzes the conversion of heme into biliverdin, iron and carbon monoxide ([@gkt243-B7]). Two isoforms of heme oxygenase have been characterized: an inducible enzyme (heme oxygenase-1, HO-1) and a constitutive isoform (heme oxygenase-2, HO-2) ([@gkt243-B7]). *HO-1* gene expression is sensitive to the substrate heme ([@gkt243-B8]) and various environmental stressors, such as cadmium ([@gkt243-B9]), lipopolysaccharide ([@gkt243-B10]), nitric oxide ([@gkt243-B11]) and oxidative stress ([@gkt243-B12]). The 5′-flanking region of the human *HO-1* gene contains several binding sites for transcription factors, such as the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) responsive element, cadmium responsive element and antioxidant responsive element (ARE). In the human *HO-1* gene locus, the regions at −4 and −9 kb upstream of the transcription start site, called enhancer 1 (E1) and enhancer 2 (E2), respectively ([@gkt243-B13],[@gkt243-B14]), contain multiple ARE sites ([@gkt243-B15]). The AREs in these enhancers overlap with TPA responsive elements and respond to multiple environmental stressors. Therefore, AREs in the *HO-1* gene enhancers are also referred to as stress responsive elements ([@gkt243-B16]). On oxidative stress, the nuclear factor erythroid-derived 2(NF-E2)--related factor 2 (Nrf2)--small Mafs heterodimer binds to E1 and E2 stress responsive elements and up-regulates *HO-1* gene expression ([@gkt243-B17]).

Nrf2 belongs to the CNC (Cap'n'collar) transcription factor family, which is characterized by a highly conserved basic region leucine-zipper structure ([@gkt243-B18]). On exposure to oxidative stress or electrophiles, Nrf2 translocates to the nucleus, where it binds to AREs via heterodimerization with small Maf proteins and activates the expression of \>100 target genes, including *HO-1* and the thioredoxin reductase 1 gene (*TXNRD1*) ([@gkt243-B19]).

Previously, we showed that BRG1 (Brahma-related gene 1), a core ATPase subunit of chromatin remodeling complexes, interacts with Nrf2 and selectively induces Nrf2-dependent *HO-1* gene expression ([@gkt243-B20],[@gkt243-B21]). In addition, we demonstrated that the Nrf2-BRG1 complex enhances human *HO-1* gene promoter activity, which partially depends on the presence of thymine--guanine (TG) repeats in the promoter sequence ([@gkt243-B20]). However, it remains unknown whether the native human *HO-1* gene promoter forms Z-DNA.

In this study, we developed a strategy for the detection of Z-DNA formation in cultured cells. Using this method, we demonstrated that the human *HO-1* gene promoter adopts a Z-DNA structure in response to the Nrf2 activator diethyl maleate (DEM). Furthermore, the dynamics of Z-DNA formation during *HO-1* gene transcriptional activation were examined.

MATERIALS AND METHODS
=====================

Cell culture
------------

Human adrenal carcinoma SW13, 293 T-REx-3xFLAG-human Nrf2/Z-probe\* cells were maintained in Dulbecco's modified Eagle medium (Sigma-Aldrich) containing 10% fetal bovine serum and 100 U/ml penicillin--streptomycin (Gibco). Human cervix carcinoma HeLa cells were cultured in RPMI 1640 medium (Sigma-Aldrich) containing 10% fetal bovine serum and 100 U/ml penicillin--streptomycin. The cells were cultured at 37°C with 5% CO~2~ and saturated humidity.

Construction of plasmids
------------------------

To construct a mammalian Z-probe expression vector, a cDNA fragment encoding human adenosine deaminase acting on double-stranded RNA 1 (ADAR1) Zα was PCR amplified using SW480 cDNA as a template with the following primers: 5′-GGG GTA CCG CCA CCA TGG TGC TGA GTA TCT ACC AAG ATC-3′ and 5′-CCG CTC GAG TCC GCT GTG CTG GTT CCA AGC-3′. A double-stranded DNA fragment encoding the SV40 nuclear localization signal (NLS) was generated after annealing the following sense and antisense strands, respectively: 5′-CCG CTC GAG CCT CCT AAG AAG AAG CGC AAA GTC GAG GGA TCC CG-3′ and 5′-CGG GAT CCC TCG ACT TTG CGC TTC TTC TTA GGA GGC TCG AGC GG-3′. The enhanced green fluorescence protein (EGFP) cDNA fragment was PCR amplified using the pEGFP-N1 vector (Clontech) as a template with the following primers: 5′-GAA GAT CTA TGG TGA GCA AGG GCG AGG A-3′ and 5′-GGG GGC CCT TAC TTG TAC AGC TCG TCC A-3′. These three DNA fragments were digested with following restriction enzymes: Zα: KpnI--XhoI; SV40 NLS: XhoI--BamHI; and the EGFP fragment: BglII--ApaI. The digestion products were ligated and cloned into pcDNA3 to generate pcDNA-Zα-NLS-EGFP. Subsequently, to insert (Gly~4~--Ser)~3~ linker amino acid residues between Zα and NLS in the pcDNA-Z-probe, the following annealed double-stranded oligonucleotides were ligated using the In-Fusion Cloning Kit (Clontech): 5′-GGT GGA GGA GGT TCT GGA GGC GGT GGA AGT GGT GGC GGA GGT AGC-3′. To introduce N173A and Y177A mutations ([@gkt243-B22]) in the Z-probe (Z~mut~-probe), PCR-based site-directed mutagenesis was performed using the following primers: 5′-TGG GAC TCC GAA GAA AGA AAT CGC TCG AGT TTT AGC CTC CCT GGC AAA GAA GG-3′ and 5′-CCT TCT TTG CCA GGG AGG CTA AAA CTC GAG CGA TTT CTT TCT TCG GAG TCC CA-3′. To construct the recombinant Z-probe or Z~mut~-probe expression vectors, the Zα or Z~mut~-probe DNA fragments were PCR amplified using pcDNA-Z-probe or pcDNA-Z~mut~-probe templates, respectively, with the following primers: 5′-CGG GAT CCA AAT GGT GCT GAG TAT CT-3′ and 5′-GGC GTC GAC TTA CTT GTA CAG CTC GTC CA-3′. These fragments were digested with BamHI and SalI and cloned into the BamHI--SalI site of pGEX-4T-3 to generate pGEX-Z-probe or pGEX- Z~mut~-probe, respectively. The sequences of all constructs were confirmed through DNA sequencing. The detailed diagram of Z-probes, including the residue numbers and boundaries between the Zα domain of human ADAR and other domains, is shown in [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1).

Gel shift assay
---------------

A 5′-Cy5-labeled annealed oligonucleotide of 18 TG repeats (TG~18~) was used as a probe. Non-labeled TG~18~ repeat, GC~18~ repeat and TA~18~ repeat oligonucleotides were used as competitors. Recombinant GST-Z-probe, GST-Z~mut~-probe and GST-NLS-EGFP proteins were purified using glutathione sepharose 4B (GE Healthcare). The purified proteins were analyzed using SDS--PAGE and stored at −30°C until further use. The oligonucleotide probe was incubated in the binding buffer containing 20 mM Tris--HCl (pH 8.5), 10 mM MgCl~2~, 1 mM dithiothreitol (DTT), 225 mM KCl and 1 mM cobalt hexamine chloride at room temperature for 30 min, and subsequently, the recombinant proteins were mixed with probe solutions at room temperature for 30 min. The samples were subjected to 4.5% acrylamide/0.5× Tris-Borate EDTA (TBE) gel and electrophoresed at 65 volts for 150 min at 4°C. The signals were detected using an FLA9000 Fluorescence imager (GE Healthcare).

Fluorescence microscopic observation
------------------------------------

The mammalian Z-probe, Z~mut~-probe or NLS-EGFP expression vectors were transiently transfected into HeLa cells using FuGENE HD reagent (Roche). After transfection, the cells were fixed with 3.7% formaldehyde at 4°C for 15 min, and the nuclei were stained using 4′,6-diamidino-2-phenylindole (DAPI). The Z-probes and nuclei were visualized using the AF6500 Fluorescence imaging system (Leica).

Chromatin immunoprecipitation assay
-----------------------------------

Chromatin immunoprecipitation (ChIP) assays were performed as previously described, with few modifications ([@gkt243-B23]). Briefly, the cells were fixed with 1% formaldehyde for 10 min at room temperature. Subsequently, glycine was added to a final concentration of 0.125 M, and the cells were incubated for 5 min at room temperature. The fixed cells were sonicated and centrifuged, and the supernatant fraction was used as the cell lysate in the ChIP analysis. Anti-Nrf2 (Santa Cruz, H300), anti-BRG1 (Abcam, ab4081), anti-FLAG M2 (SIGMA) and anti-Pol II (Millipore, clone CTD4H8) antibodies were used. Normal rabbit IgG (Millipore) was used as a negative control. These antibodies were immobilized to Dynabeads Protein G (Life Technologies) and used for the immunoprecipitation reactions. The precipitated DNA fragments were detected using real-time PCR with the following primers: *HO-1* E2 enhancer region (*HO-1*-E2): 5′-CCC TGC TGA GTA ATC CTT TCC-3′ and 5′-GGC GGT GAC TTA GCG AAA AT-3′; *HO-1* gene promoter region (*HO-1*-Pro): 5′-GCC AGA AAG TGG GCA TCA G-3′ and 5′-CTG AGG ACG CTC GAG GGA G-3′; *HO-1* Exon 3 region (*HO-1*-Ex3): 5′-CAC CAA GTT CAA GCA GCT CTA C-3′ and 5′-CTT CTA TCA CCC TCT GCC TGA C-3′; *TXNRD1* ARE region (*TXNRD1*-ARE): 5′-TGC ACG AGG AGT GGA TTT CTG CTT-3′ and 5′-GCT GCA AAT GCC GGA GTG AAG AAA-3′; and the γ-globin gene (*HGB2*) promoter region (*HGB2*-Pro): 5′-TGG CTA GGG ATG AAG AAT AAA AGG-3′ and 5′-ATT GAT AAC CTC AGA CGT TCC AGA AG-3′.

Z-DNA detection
---------------

The expression plasmids were transiently transfected into SW13 and HeLa cells using FuGENE HD (Roche). The siRNA against human Nrf2 was synthesized at QIAGEN using the following sequence: 5′-AAG AGU AUG AGC UGG AAA AACdTdT-3′ ([@gkt243-B24]). At 24 h after plasmid transfection, siRNA (final 20 nM) was transfected using Lipofectamine RNAi Max reagent according to the manufacturer's protocol (Life Technologies). At 24 h after siRNA transfection, the cells were exposed to 100 µM of DEM. The 293T-REx-3xFLAG-human Nrf2/Z-probe\* cells were treated with 1 µg/ml tetracycline (Tet). The anti-GFP antibody (Clontech) was immobilized to Dynabeads Protein G and used in the immunoprecipitation experiments. Precipitated DNA fragments were detected using real-time PCR with the following primers: *CSF1* TG repeat region (*CSF1*-TG): 5′-CGC AGA AGA CAG AGG GTG AC-3′ and 5′-GGC ATG TGG TTT ATG GGA AA-3′; −3600 upstream from the *CSF1* transcription start site (*CSF1*-3600): 5′-ACA AGG GCA TTC AGT CCA AA-3′ and 5′-AGA CAG CGT GAA GGG TGG TA-3′; *CSF1* Exon 4 region (*CSF1*-Ex4): 5′-TCA GAG ATA ACA CCC CCA ATG-3′ and 5′-CTT CAT AAT CCT TGG TGA AGC A-3′; and *HO-1* TG repeat region (*HO-1*-TG): 5′-CTC TGG AAG GAG CAA AAT CAC A-3′ and 5′-GGC CAT AGG ACT TTT AGA GAA AAC A-3.

Nucleosome occupancy detection
------------------------------

The protocol for nucleosome occupancy detection was modified from a previously described method ([@gkt243-B25]). Briefly, formaldehyde-fixed cells were permeabilized with 5 mM PIPES--KOH (pH 8.0), 85 mM KCl and 1 mM DTT containing 0.5% NP40, and the chromatin was digested with 2000 U of micrococcal nuclease (New England BioLabs) for 10 min at 37°C. The digestion was terminated after the addition of 10 mM EDTA, and the cells were lysed and centrifuged. The supernatant fraction was used in the ChIP assay. Antibodies against histone H3 (Millipore, clone A3S) or normal mouse IgG (Millipore) were immobilized to Dynabeads Protein G and used for immunoprecipitation experiments. The *HO-1* TG repeat region and *TXNRD1* ARE region in the precipitated DNA fragments were detected using real-time PCR with the primers described above.

Gene expression analysis
------------------------

The cDNAs were synthesized using PrimeScript® RTase (TaKaRa Bio) and total RNA as a template. The real-time PCR analyses were performed using SYBR® Premix Ex Taq™ II (Perfect Real Time; Takara Bio) and a CFX Real-Time PCR Detection System (BioRad). The cyclophilin A gene was used as an internal control with the following primers: 5′-ATG CTG GAC CCA ACA CAA AT-3′ and 5′-TCT TTC ACT TTG CCA AAC ACC-3′. The gene expression was measured using real-time PCR with the following primers: *CSF1*: 5′-GTT TGT AGA CCA GGA ACA GTT GAA-3′ and 5′-TGT ACC AGG AGA AAT GCC TTC-3′; *HO-1*: 5′-CCA GCA ACA AAG TGC AAG ATT C-3′ and 5′-TCA CAT GGC ATA AAG CCC TAC AG-3′; and *TXNRD1*: 5′-ACA CAA AGC TTC AGC ATG TCA-3′ and 5′-CAA TTC CGA GAG CGT TCC-3′.

Statistical analysis
--------------------

The results were expressed as the means ± standard error of the mean (SEM), and the statistical significance was determined using Dunnett's test for multiple-parameter comparisons or two-tailed unpaired Student's *t-*test for two-parameter comparisons. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

The recombinant Z-probe binds to a Z-DNA-forming sequence *in vitro*
--------------------------------------------------------------------

The Z-DNA-forming sequences, such as d(CG)~n~ and d(TG)~n~, easily form Z-DNA structures under high salt conditions *in vitro*, but the *in vivo* formation of Z-DNA structures in the human *HO-1* TG repeat region has not been demonstrated. Thus, we developed a method for the detection of Z-DNA structures on genomic DNA in cultured cells. [Figure 1](#gkt243-F1){ref-type="fig"} illustrates our strategy for the detection of Z-DNA formation in genomic DNA. We generated a fusion protein consisting of the Zα domain of human ADAR1, a well-characterized Z-DNA-binding domain ([@gkt243-B26]), (Gly~4~--Ser)~3~ flexible linker residues (Ln), an NLS and EGFP, which was referred to as the Z-probe ([Figure 1](#gkt243-F1){ref-type="fig"} and [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1)). A similar probe was previously used to detect the distribution of Z-DNA in the human genome ([@gkt243-B27]), but in the present study, the Z-probe was fused with EGFP to visualize the localization of the probe in the living cultured cells and serve as an antigen for the ChIP assay using an anti-GFP antibody. After ChIP, the Z-DNA formation was quantitatively measured using real-time PCR. As a negative control, we generated a Z~mut~-probe carrying N173A and Y177A mutations (numbers corresponds to human ADAR1 residues) in the Zα domain of the Z-probe, which disrupt Z-DNA binding ([@gkt243-B22]) ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1) and [Figure 2](#gkt243-F2){ref-type="fig"}A and B). Figure 1.Strategy for the detection of genomic Z-DNA formation. To detect Z-DNA formation, a mammalian expression vector was constructed containing the ADAR1 Z-DNA-binding domain Zα, a (Gly~4~--Ser)~3~ flexible linker, an NLS and EGFP, called the Z-probe. The cultured cells were transfected with the Z-probe expression vector and subjected to an appropriate stress. Subsequently, Z-DNA formation was quantitatively measured using a ChIP assay with an anti-GFP--specific antibody, followed by real-time PCR using specific primer sets. Figure 2.The recombinant Z-probe binds to a Z-DNA-forming sequence *in vitro*. (**A**) A schematic figure of the recombinant proteins. 1: NLS-EGFP; 2: Z-probe; 3: Z~mut~-probe. The proteins were expressed as GST fusion proteins and purified using glutathione-conjugated beads. Zα: human ADAR1 Zα domain; Zα~mut~: the Zα domain possessing N173A and Y177A mutations corresponding to human ADAR1 residue numbers; Ln: (Gly~4~--Ser)~3~ linker residues. Detailed information is provided as [Supplemental Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1). (**B**) SDS--PAGE analysis of the purified recombinant proteins. 1: GST-NLS-EGFP; 2: GST-Z-probe; 3: GST-Z~mut~-probe. A gel shift assay was performed using Cy5-labeled d(TG/AC)~18~ double-stranded oligonucleotides as probes. (**C**) The purified GST-NLS-EGFP vector (lanes 2--4), GST-Z-probe (lanes 5--7) and GST-Z~mut~-probe (lanes 8--10) were incubated with a Cy5-labeled oligonucleotide probe. Protein--DNA complexes were separated using native PAGE, and the fluorescence signals were detected using Typhoon FLA9000. (**D**) The GST-Z-probe (lanes 12--15) was incubated with excess non-labeled competitors (lanes 13--15) and mixed with a Cy5-labeled probe. Subsequently, the protein--DNA complexes were separated using native PAGE, and the fluorescence signals were detected. Competitors: TG: d(TG/AC)~18~ (lane 13); TA: d(TA/AT)~18~ (lane 14); GC: d(GC/CG)~18~ (lane 15).

To validate whether the Z-probe specifically binds to Z-DNA, we generated a GST fusion protein of the Z-probe and performed a gel shift assay using double-stranded TG~18~ repeats as a probe ([Figure 2](#gkt243-F2){ref-type="fig"}). Consistent with the previous result ([@gkt243-B22]), the recombinant Z-probe, but not the Z~mut~-probe, strongly and specifically bound to the TG~18~ repeats ([Figure 2](#gkt243-F2){ref-type="fig"}C). The binding of the Z-probe to TG~18~ repeats was inhibited after the addition of excess TG~18~ or GC~18~ repeat oligonucleotides, which form Z-DNA. In contrast, the addition of TA~18~ repeats did not inhibit Z-probe binding to Z-DNA as efficiently as TG~18~ or GC~18~ repeats ([Figure 2](#gkt243-F2){ref-type="fig"}D). These results indicate that the recombinant Z-probe specifically binds to Z-DNA *in vitro.*

The Z-probe specifically binds to the TG repeats of the *CSF1* promoter in cultured cells
-----------------------------------------------------------------------------------------

To detect Z-DNA formation in cultured cells, we constructed a mammalian expression plasmid for the Z-probe and investigated the localization of the Z-probe in HeLa cells. The fluorescent microscopic observation revealed that the Z-probe and Z~mut~-probe showed similar localization patterns in the nuclei ([Figure 3](#gkt243-F3){ref-type="fig"}). Figure 3.Z-probes are localized in the nucleus. HeLa cells were transfected with the expression vectors for the Z-probe, Z~mut~-probe or NLS-EGFP. The cells were observed using a fluorescence microscope at 24 h after transfection. The Z-probe, Z~mut~-probe and NLS-EGFP proteins are shown in green. The nuclei were stained with DAPI (blue).

To confirm whether the Z-probe binds to Z-DNA in cultured cells, we performed a ChIP assay using an anti-GFP antibody. It has been reported that the human colony stimulating factor 1 gene (*CSF1*) promoter contains a TG repeat sequence and adopts a Z-DNA structure in a BRG1-dependent manner in SW13 cells ([@gkt243-B28],[@gkt243-B29]). Thus, we examined the *CSF1* promoter region as a positive control for Z-DNA formation. We confirmed the overexpression of FLAG-BRG1 through immunoblot analysis using the anti-FLAG antibody ([Figure 4](#gkt243-F4){ref-type="fig"}A) and detected the BRG1-dependent induction of *CSF1* gene expression in SW13 cells ([Figure 4](#gkt243-F4){ref-type="fig"}B). BRG1 significantly induced the binding of the Z-probe, but not the Z~mut~-probe, to the *CSF1*-TG repeat sequence ([Figure 4](#gkt243-F4){ref-type="fig"}C and D). In addition, BRG1 did not enhance the binding of the Z-probe to either the *CSF1*-3600 or *CSF1*-Ex4 regions ([Figure 4](#gkt243-F4){ref-type="fig"}D). These results indicate that the Z-probe specifically detects Z-DNA formation in the *CSF1* promoter in cultured cells. Figure 4.Detection of BRG1-dependent Z-DNA formation in the human *CSF1* promoter using the Z-probe. (**A**) SW13 cells were transfected with the Z-probe or Z~mut~-probe together with the BRG1 expression vector as indicated in the figure. Whole-cell lysates were separated using SDS--PAGE, and the protein expression was analyzed through immunoblotting using specific antibodies as indicated in the figure. (**B**) SW13 cells were transfected with BRG1 together with the Z-probe (lanes 1 and 2) or Z~mut~-probe (lane 3) expression vectors, and the *CSF1* gene expression was analyzed using real-time PCR. The value of lane 1 was arbitrarily set as 1, and the relative expression levels were expressed as the means ± SEM of four independent assays. (**C**) A schematic figure of the human *CSF1* gene locus and regions detected using ChIP analysis. +1: transcription start site; ZZZ: *CSF1*-TG repeat region; Ex4: *CSF1* Exon 4 region. (**D**) The SW13 cells were transfected with the Z-probe or Z~mut~-probe together with BRG1 expression vectors, and subsequently, a ChIP assay was performed using an anti-GFP antibody (black bars). Normal rabbit IgG was used as a negative control (gray bars). Fold Z-DNA formation was measured using real-time PCR with specific primer sets for the upstream region of the *CSF1* promoter (*CSF1*-3600), the *CSF1*-TG or *CSF1*-Ex4 regions. The anti-GFP ChIP value in lane 1 is set as 1, and the relative binding values are expressed as the means ± SEM of four independent assays. ^\#^*P* \< 0.05 and ^\#\#^*P* \< 0.01 compared with the value of lane 1 (Dunnett's test for multiple parameter comparisons); ns: no significant difference. The lane numbers correspond to the cells transfected in (A).

Human *HO-1* gene promoter forms Z-DNA in response to Nrf2-activating agent DEM
-------------------------------------------------------------------------------

To investigate Z-DNA formation in the human *HO-1*-TG repeat region, we transiently transfected Z-probe expression plasmids into HeLa cells, and the cells were exposed to DEM. As expected, DEM induced Nrf2 protein expression and *HO-1* and thioredoxin reductase 1 gene (*TXNRD1*) expression in HeLa cells ([Figure 5](#gkt243-F5){ref-type="fig"}A and B). The ChIP analysis demonstrated that DEM treatment significantly induced Z-probe binding to the human *HO-1*-TG repeats, but not to either of the *HO-1-*Ex3 or *TXNRD1* ARE regions ([Figure 5](#gkt243-F5){ref-type="fig"}C and D). In contrast, Z~mut~-probe binding to the *HO-1-*TG region was not induced ([Figure 5](#gkt243-F5){ref-type="fig"}D). These results indicate that Z-DNA formation in the human *HO-1* gene promoter is associated with Nrf2 activation in HeLa cells. Figure 5.Human *HO-1* gene promoter adopts a Z-DNA form in response to Nrf2-activating agent DEM. HeLa cells were transfected with the Z-probe (lanes 1 and 2) or Z~mut~-probe (lane 3) expression vectors. At 24 h after transfection, the cells were untreated (lane 1) or treated with 100 µM DEM for 3 h (lanes 2 and 3). (**A**) Whole-cell lysates were separated using SDS--PAGE, and the protein expression was analyzed through immunoblotting using specific antibodies, as indicated in the figure. (**B**) The gene expression was analyzed through real-time PCR using primers specific for the *HO-1* and *TXNRD1* genes. The value of lane 1 is set as 1, and the relative expression values are expressed as the means ± SEM of five independent assays. (**C**) A schematic figure of the human *HO-1* and *TXNRD1* gene loci and regions as detected through ChIP analysis. E2: E2 enhancer; E1: E1 enhancer; +1: transcription start site; ZZZ: *HO-1*-TG repeat region; Pro: *HO-1* gene promoter region; Ex3: *HO-1* Exon 3 region; *TXNRD1*-ARE: *TXNRD1* ARE region. (**D**) HeLa cells were transfected with the Z-probe or Z~mut~-probe, and subsequently, the cells were exposed to 100 µM DEM for 3 h. After DEM treatment, a ChIP assay was performed using an anti-GFP antibody (black bars). Normal rabbit IgG was used as a negative control (gray bars). The amount of precipitated DNA was measured through real-time PCR using specific primer sets for the *HO-1*-TG, *HO-1*-Ex3 and *TXNRD1* ARE regions. The anti-GFP ChIP value of lane 1 is set as 1, and the relative bindings are expressed as the means ± SEM of five independent assays. ^\#^*P* \< 0.05 and ^\#\#^*P* \< 0.01 compared with the value of lane 1 (Dunnett's test for multiple parameter comparisons); ns: no significant difference. The lane numbers correspond with the treatments in (A).

Z-DNA formation in the *HO-1*-TG region precedes *HO-1* gene induction
----------------------------------------------------------------------

Using a luciferase reporter analysis of the *HO-1* gene promoter construct, we previously showed that the Z-DNA-forming TG repeat sequence enhances *HO-1* transcription ([@gkt243-B20]). Therefore, we examined the effects of Z-DNA formation on *HO-1* gene expression. The apparent induction of *HO-1* gene expression occurred at 2 h after DEM treatment and continued to increase over 6 h ([Figure 6](#gkt243-F6){ref-type="fig"}A). Z-DNA formation was induced as early as 1 h after DEM treatment and remained relatively constant during the time course ([Figure 6](#gkt243-F6){ref-type="fig"}B). These results indicate that Z-DNA formation in the *HO-1*-TG region precedes *HO-1* gene induction. Figure 6.Dynamics of Z-DNA formation, Pol II recruitment and nucleosome occupancy on the *HO-1* regulatory region in response to DEM. HeLa cells were transfected with the Z-probe expression vector, and at 24 h after transfection, the cells were exposed to 100 µM DEM for various amounts of time as indicated. (**A**) *HO-1* gene expression was analyzed through real-time PCR using an *HO-1*-specific primer set. (**B--D**) The ChIP assays were performed using anti-GFP, anti-Pol II and anti-H3 antibodies. Z-DNA formation was measured through real-time PCR using a specific primer set for the *HO-1* TG repeat region (*HO-1*-TG; B). Nucleosome occupancy was measured through real-time PCR using specific primer sets for the *HO-1* TG repeat (*HO-1-*TG) and the *TXNRD1* ARE (*TXNRD1*-ARE) regions (C). The value (%) at 0 h is set as 100, and the relative changes are expressed as the means ± SEM of three independent assays. Pol II recruitment was measured through real-time PCR using specific primer sets for the *HO-1* gene promoter (*HO-1-Pro*), *TXNRD1* gene in the ARE region (*TXNRD1*-ARE) and γ-globin promoter region (*HGB2*-Pro) (D). The values are shown in IP/input, and the relative changes are expressed as the means ± SEM of three independent assays. ^\#^*P* \< 0.05 and ^\#\#^*P* \< 0.01 compared with the value at 0 h (Dunnett's test for multiple parameter comparisons).

We hypothesized that if the Z-DNA formation participates in transcription activation, nucleosome occupancy on the *HO-1*-TG region would be reduced. Thus, we performed ChIP assay using anti-histone H3 for the detection of nucleosome occupancy. For this purpose, we used micrococcal nuclease digestion instead of sonication before immunoprecipitation, as previously described ([@gkt243-B25]). As shown in [Figure 6](#gkt243-F6){ref-type="fig"}C, we demonstrated that nucleosome occupancy in the *HO-1*-TG region, but not in the *TXNRD1*-ARE, was rapidly reduced in response to DEM treatment. Moreover, Pol II recruitment was significantly induced after DEM treatment in the *HO-1* gene promoter region, but not in the *TXNRD1* ARE region ([Figure 6](#gkt243-F6){ref-type="fig"}D). These results suggest that Z-DNA formation is actively involved in the transcription regulation of the *HO-1* gene.

We previously demonstrated that BRG1 interacts with Nrf2, selectively inducing *HO-1* gene expression ([@gkt243-B20],[@gkt243-B21]). Thus, we analyzed the dynamics of Nrf2 and BRG1 recruitment to the *HO-1* regulatory region. Nrf2 binding to the *HO-1*-E2 enhancer region was significantly induced after DEM treatment, with peak Nrf2 binding observed 1 h after DEM administration ([Figure 7](#gkt243-F7){ref-type="fig"}A). Along with Nrf2 enhancer binding, the BRG1 binding to the *HO-1*-E2 enhancer was observed at 1 h after DEM treatment and gradually increased until 6 h ([Figure 7](#gkt243-F7){ref-type="fig"}A). Although we did not detect a significant change in Nrf2 binding to the *HO-1* gene promoter, DEM induced BRG1 binding to this region, with peak binding observed after 2 h ([Figure 7](#gkt243-F7){ref-type="fig"}B). These results are consistent with our previous report that BRG1 is positively involved in Z-DNA formation ([@gkt243-B20]). Figure 7.Dynamics of Nrf2 and BRG1 on the *HO-1* regulatory region in response to DEM. HeLa cells were transfected with the Z-probe expression vector, and at 24 h after transfection, the cells were treated with 100 µM DEM for various amounts of time, as indicated. ChIP assays were performed using anti-Nrf2 and anti-BRG1 antibodies. Nrf2 and BRG1 binding were measured through real-time PCR using specific primer sets for the *HO-1* E2 enhancer (*HO-1*-E2; **A**) or *HO-1* gene promoter (*HO-1*-Pro; **B**) regions. The value at 0 h is set as 1, and the relative changes are expressed as the means ± SEM of four independent assays. ^\#^*P* \< 0.05 compared with the value at 0 h (Dunnett's test for multiple parameter comparisons).

Nrf2 activation is associated with Z-DNA formation in the human *HO-1* gene promoter
------------------------------------------------------------------------------------

To determine whether Nrf2 is required for DEM-inducible Z-DNA formation in the human *HO-1-*TG repeat region, we knocked down endogenous Nrf2 using Nrf2-specific siRNA. The effect of Nrf2 siRNA was confirmed through immunoblot analysis using an Nrf2-specific antibody ([Figure 8](#gkt243-F8){ref-type="fig"}A). The Nrf2 knockdown significantly and effectively reduced the gene expression of both *HO-1* and *TXNRD1* in response to DEM treatment ([Figure 8](#gkt243-F8){ref-type="fig"}B). DEM-induced Z-DNA formation in the *HO-1*-TG region was significantly reduced through Nrf2 knockdown compared with control siRNA transfection ([Figure 8](#gkt243-F8){ref-type="fig"}C). In the *TXNRD1* ARE region, we did not detect any DEM-inducible Z-DNA formation in control siRNA--transfected cells ([Figure 8](#gkt243-F8){ref-type="fig"}C). BRG1 binding to the *HO-1* gene promoter was induced after DEM treatment in control siRNA cells, but not in Nrf2 knockdown cells ([Figure 8](#gkt243-F8){ref-type="fig"}D). Figure 8.Nrf2 knockdown reduces the DEM-induced Z-DNA formation in the human *HO-1*-TG region. HeLa cells were transfected with the Z-probe expression vector, and at 24 h after transfection, the cells were transfected with control siRNA (Control) or Nrf2-specific siRNA (Nrf2) and treated with 100 µM DEM for 3 h. (**A**) Whole-cell lysates were separated using SDS--PAGE, and the protein expression was analyzed through immunoblotting using specific antibodies, as indicated in the figure. (**B**) *HO-1* and *TXNRD1* gene expression were analyzed through real-time PCR using specific primer sets. The value of lane 1 is arbitrarily set as 1, and the relative expressions are expressed as the means ± SEM of three independent assays. (**C** and **D**) A ChIP assay was performed using anti-GFP (C) or anti-BRG1 antibodies (black bars; D). Normal rabbit IgG was used as a negative control (gray bars). The Z-DNA formation was measured through real-time PCR using specific primer sets for the *HO-1*-TG and *TXNRD1* ARE regions (C). BRG1 binding was measured through real-time PCR using a specific primer set for the *HO-1* gene promoter region (*HO-1*-Pro; D). The anti-GFP ChIP (C) or anti-BRG1 ChIP (D) values of lane 1 are set as 1, and the relative bindings are expressed as the means ± SEM of three independent assays. \*\**P* \< 0.01(two-tailed unpaired Student's *t*-test). The lane numbers correspond with the treatments in (A).

To investigate whether Nrf2 activation is sufficient for the induction of Z-DNA formation in the human *HO-1*-TG repeat region, we examined Z-DNA formation in the *HO-1* gene promoter in 293T-REx-FLAG-human Nrf2/Z-probe\* cells, possessing a stably integrated Z-probe\* and Tet-inducible Nrf2 cassettes. Note that the Z-probe\* protein has no flexible linker between Zα and NLS ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1)), but similar to the Z-probe, Z-probe\* specifically detects Z-DNA formation both *in vitro* and *in vivo* (data not shown). Tet administration to the cells induced FLAG-Nrf2 protein expression ([Figure 9](#gkt243-F9){ref-type="fig"}A) and *HO-1* gene expression ([Figure 9](#gkt243-F9){ref-type="fig"}B). Tet treatment also induced Nrf2 binding to the *HO-1*-E2 enhancer region ([Figure 9](#gkt243-F9){ref-type="fig"}C). Moreover, Tet significantly enhanced BRG1 binding to the *HO-1* gene promoter at 3 h ([Figure 9](#gkt243-F9){ref-type="fig"}D). Consistent with BRG1 recruitment, we detected a substantial induction of Z-DNA formation in the *HO-1-*TG repeat region from 0.5 to 3 h after Tet administration, although we did not detect statistical significances ([Figure 9](#gkt243-F9){ref-type="fig"}E). Taken together, these results indicate that Z-DNA formation in the TG repeat region is associated with Nrf2 activation. Figure 9.Nrf2 activation is sufficient to induce Z-DNA formation in the human *HO-1*-TG region. 293T-REx-FLAG-human Nrf2 cells stably expressing the Z-probe\* were treated with Tet for the indicated periods of time. (**A**) Whole-cell lysates were separated using SDS--PAGE, and the protein expression was analyzed through immunoblotting using specific antibodies, as indicated in the figure. (**B**) The *HO-1* gene expression after Tet administration was analyzed through real-time PCR using specific primer sets. The value at time 0 h was arbitrarily set as 1, and the relative expression values are expressed as the means ± SEM of three independent assays. (**C**) Nrf2 binding to the human *HO-1* E2 enhancer (*HO-1*-E2) was analyzed through ChIP using an anti-FLAG antibody. (**D**) BRG1 recruitment to the human *HO-1* gene promoter (*HO-1*-Pro) was analyzed through ChIP using an anti-BRG1 antibody. (**E**) Z-DNA formation was measured through real-time PCR using a specific primer set for the *HO-1* TG repeat region (*HO-1*-TG). The value at 0 h is arbitrarily set as 1, and the relative bindings are expressed as the means ± SEM of three independent assays. ^\#^*P* \< 0.05 and ^\#\#^*P* \< 0.01, compared with the values at 0 h (Dunnett's test for multiple parameter comparisons).

DISCUSSION
==========

In this study, we developed a Z-DNA detection system using a Z-probe and successfully detected the induction of Z-DNA formation in the human *HO-1-*TG repeat region in cultured cells ([Figures 4--6](#gkt243-F4 gkt243-F5 gkt243-F6){ref-type="fig"} and [9](#gkt243-F9){ref-type="fig"}). These results showed that the human *HO-1*-TG repeat in the genome adopts a Z-DNA structure in response to DEM treatment.

Although these results suggest that Nrf2 induces Z-DNA formation in the *HO-1* gene promoter, the possibility that Z-DNA is constitutively formed in the *HO-1*-TG region and that Z-DNA is detected after Nrf2 activation cannot be excluded, as the surrounding chromatin structure is relaxed after Nrf2 activation, allowing the Z-probe to access the Z-DNA structure. To avoid the effect of the 3D chromatin structure in Z-DNA detection, we fixed the cells with formaldehyde in the absence of Z-probe and subsequently sonicated the chromatin before precipitating the Z-DNA through GST-affinity purification using the recombinant GST-Z-probe or immunoprecipitation assay using the anti-Z-DNA antibody. Unfortunately, we did not detect the precipitation of both *HO-1*-TG region and *CSF1*-TG region in BRG1-overexpressed SW13 cells using either method (data not shown). However, a significant amount of Pol II was bound to the *HO-1* gene promoter before DEM administration compared with the γ-globin promoter (*HGB2*-Pro), which is exclusively expressed in the erythroid cell linage ([Figure 6](#gkt243-F6){ref-type="fig"}D). This result suggests that the *HO-1* gene promoter region is in a relatively open structure, as previously reported in mouse cells ([@gkt243-B30]), and these regions are accessible to the Z-probe, even before DEM administration.

We detected slight, but significant, binding of Z-probe to non--Z-DNA-forming sequences of the *CSF1* gene (i.e. *CSF1*-3600 and *CSF1*-Ex4) in an N173- and Y177-dependent manner ([Figure 4](#gkt243-F4){ref-type="fig"}D). Ha *et al.* ([@gkt243-B31]) previously reported that the Zα domain of ADAR1 recognizes non--CG-repeat Z-DNA-forming sequences, such as d(CACGTG)~2~ and d(CGGCCG)~2~. Because the binding of the Z-probe to non--Z-DNA-forming sequences is not significantly enhanced by BRG1, we propose that *CSF1*-3600 and *CSF1*-Ex4 regions form weak Z-DNA structures that are not augmented through BRG1. These notions should be clarified in the future.

We demonstrated that Nrf2 is necessary and sufficient for the Z-DNA formation at the *HO-1* gene promoter ([Figures 8](#gkt243-F8){ref-type="fig"} and [9](#gkt243-F9){ref-type="fig"}). Because we previously indicated that BRG1 was an important co-factor of Nrf2 in the induction of Z-DNA formation ([@gkt243-B20]), we also investigated the role of BRG1 using a BRG1 knockdown. However, we could not clarify the precise role of BRG1 in Z-DNA formation, as Nrf2 protein expression was substantially attenuated after BRG1 knockdown in HeLa cells ([Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gkt243/-/DC1)). Thus, the role of BRG1 in Z-DNA formation in the *HO-1*-TG region requires further clarification.

We showed that the human *HO-1* gene promoter region transiently adopts a Z-DNA structure in response to Nrf2 activation treatment ([Figures 6](#gkt243-F6){ref-type="fig"} and [9](#gkt243-F9){ref-type="fig"}). Interestingly, the Z-DNA formation of the human *HO-1* gene promoter preceded *HO-1* mRNA induction ([Figures 6](#gkt243-F6){ref-type="fig"} and [9](#gkt243-F9){ref-type="fig"}). Thus, although some reports have suggested that Z-DNA-forming sequences are involved in the down-regulation of gene expression ([@gkt243-B32],[@gkt243-B33]), we propose that Z-DNA formation in the *HO-1* gene promoter preferentially functions as an enhancer of *HO-1* gene expression. We previously reported that *Nramp1/Slc11A1* is one of the genes regulated through Nrf2 expression in mouse macrophages ([@gkt243-B34]). Importantly, HIF1α induces Z-DNA formation in the *Nramp1* promoter ([@gkt243-B35]). In addition, TPA induces Z-DNA formation in the *Nramp1* gene promoter, and ATF3-dependent BRG1 recruitment is essential for the activation of *Nramp1* gene expression in HL60 cells ([@gkt243-B36]). Wittig *et al.* ([@gkt243-B37]) previously reported that Z-DNA is formed in the *c-myc* regulatory region of the human genome using permeated nuclei of U937 cells and an anti-Z-DNA antibody. These authors also showed that the amount of Z-DNA in the *c-myc* region is diminished within a relatively short period after treatment with the differentiation agents TPA and vitamin D~3~, which are associated with the down-regulation of *c-myc* gene expression ([@gkt243-B37]). Collectively, the results from the present and other studies indicate that Z-DNA formation is associated with the increased expression of the *HO-1*, *Nramp1* and *c-myc* genes, although the detailed molecular mechanism of this induction remains elusive.

Because the *HO-1* gene is rapidly and strongly induced compared with other Nrf2 target genes, including the *TXNRD1* gene, we propose that the *HO-1* gene is regulated through a unique molecular mechanism. In the present study, we showed that Z-DNA formation in the human *HO-1* gene promoter is associated with Nrf2 activation ([Figures 6--9](#gkt243-F6 gkt243-F7 gkt243-F8 gkt243-F9){ref-type="fig"}). In addition, Wang *et al.* reported that Z-DNA blocks nucleosome formation, suggesting that Z-DNA formation in the gene promoter is sufficient to demarcate the boundaries of neighboring nucleosomes, producing transcriptionally favorable locations for the TATA box near the nucleosomal DNA entry site of Pol II ([@gkt243-B5]). Indeed, we showed that nucleosome occupancy at the *HO-1*-TG region was rapidly reduced in response to DEM treatment ([Figure 6](#gkt243-F6){ref-type="fig"}C). Therefore, we propose that Z-DNA formation in the human *HO-1*-TG region is one of the mechanisms underlying strong *HO-1* gene induction.

Although the correlation between susceptibility to disease and the TG-repeat length polymorphism in promoters has been reported in several genes, including *HO-1* for emphysema and *Nramp1* for type I diabetes, respectively ([@gkt243-B4],[@gkt243-B38]), the precise biological function of the Z-DNA-forming sequence remains unclear. In this study, we developed a method for the detection of Z-DNA and demonstrated that Z-DNA formation in the human *HO-1* gene promoter is associated with Nrf2 activation. Therefore, the human *HO-1* gene promoter is a good model system to understand Z-DNA formation and how Z-DNA-forming sequences regulate gene expression.
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